Artículos de revistas sobre el tema "17-OHP"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "17-OHP".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Ransom, Carla E., Jeanette R. Chin, Hilary A. Roeder, Tammy R. Sinclair, R. Phillips Heine y Amy P. Murtha. "The Influence of Prior Obstetrical History on Current 17-Hydroxyprogesterone Caproate Use". Journal of Pregnancy 2011 (2011): 1–4. http://dx.doi.org/10.1155/2011/286483.
Texto completoŞahin, Yilmaz, Demet Ayata y Fahrettin Keleştimur. "Lack of relationship between 17-hydroxyprogesterone response to buserelin testing and hyperinsulinemia in polycystic ovary syndrome". European Journal of Endocrinology 136, n.º 4 (abril de 1997): 410–15. http://dx.doi.org/10.1530/eje.0.1360410.
Texto completoSólyom, J., G. Gács, K. Keszei, K. Láng, J. Örley, I. Petheö y L. Ságodi. "Detection of late-onset adrenal hyperplasia in girls with peripubertal virilization". Acta Endocrinologica 115, n.º 3 (julio de 1987): 413–18. http://dx.doi.org/10.1530/acta.0.1150413.
Texto completoPlavšić, V., D. Rogić, M. Dumić, J. Ille, Lj Brkljačić y V. Latin. "Interferences with Determination of 17-Hydroxyprogesterone in Amniotic Fluid". Clinical Chemistry 37, n.º 12 (1 de diciembre de 1991): 2154–55. http://dx.doi.org/10.1093/clinchem/37.12.2154.
Texto completoSchreiner, Felix, Magdalini Tozakidou, Rita Maslak, Ute Holtkamp, Michael Peter, Bettina Gohlke y Joachim Woelfle. "Functional glucocorticoid receptor gene variants do not underlie the high variability of 17-hydroxyprogesterone screening values in healthy newborns". European Journal of Endocrinology 160, n.º 4 (abril de 2009): 667–73. http://dx.doi.org/10.1530/eje-08-0639.
Texto completoCavarzere, Paolo, Dinane Samara-Boustani, Isabelle Flechtner, Michèle Dechaux, Caroline Elie, Véronique Tardy, Yves Morel y Michel Polak. "Transient hyper-17-hydroxyprogesteronemia: a clinical subgroup of patients diagnosed at neonatal screening for congenital adrenal hyperplasia". European Journal of Endocrinology 161, n.º 2 (agosto de 2009): 285–92. http://dx.doi.org/10.1530/eje-09-0145.
Texto completoWallace, A. M., J. Beesley, M. Thomson, C. A. Giles, A. M. Ross y N. F. Taylor. "Adrenal status during the first month of life in mature and premature human infants". Journal of Endocrinology 112, n.º 3 (marzo de 1987): 473–80. http://dx.doi.org/10.1677/joe.0.1120473.
Texto completoMaas, Kevin H., Sandy S. Chuan, Heidi Cook-Andersen, H. Irene Su, A. Duleba y R. Jeffrey Chang. "Relationship Between 17-Hydroxyprogesterone Responses to Human Chorionic Gonadotropin and Markers of Ovarian Follicle Morphology in Women With Polycystic Ovary Syndrome". Journal of Clinical Endocrinology & Metabolism 100, n.º 1 (1 de enero de 2015): 293–300. http://dx.doi.org/10.1210/jc.2014-2956.
Texto completoIonova, T. A., N. Iu Kalinchenko, A. N. Tiul'pakov y A. N. Nizhnik. "The comparative assessment of the effectiveness of immunoanalysis and tandem mass spectrometry applied for re-testing the children with suspected congenital adrenal cortical hyperplasia". Problems of Endocrinology 59, n.º 2 (15 de abril de 2013): 12–18. http://dx.doi.org/10.14341/probl201359212-18.
Texto completoHàn, Ngọc Thùy Dương, Thị Ngọc Lan Hoàng, Thị Thu Hiền Đào, Phạm Sỹ Cường Lê, Văn Đức Phạm, Danh Cường Trần y Kim Phượng Đoàn Thị. "Phân tích một số yếu tố ảnh hưởng đến nồng độ 17-hydroxyprogesteron trong sàng lọc sơ sinh bệnh tăng sản thượng thận bẩm sinh". Tạp chí Phụ sản 19, n.º 4 (7 de marzo de 2022): 25–28. http://dx.doi.org/10.46755/vjog.2021.4.1319.
Texto completoSaedi, Saad Al, Heather Dean, William Dent, Elizabeth Stockl y Catherine Cronin. "Screening for Congenital Adrenal Hyperplasia: The Delfia Screening Test Overestimates Serum 17-Hydroxyprogesterone in Preterm Infants". Pediatrics 97, n.º 1 (1 de enero de 1996): 100–102. http://dx.doi.org/10.1542/peds.97.1.100.
Texto completoMelin, Johanna, Zinnia P. Parra-Guillen, Robin Michelet, Thi Truong, Wilhelm Huisinga, Niklas Hartung, Peter Hindmarsh y Charlotte Kloft. "Pharmacokinetic/Pharmacodynamic Evaluation of Hydrocortisone Therapy in Pediatric Patients with Congenital Adrenal Hyperplasia". Journal of Clinical Endocrinology & Metabolism 105, n.º 4 (3 de marzo de 2020): e1729-e1740. http://dx.doi.org/10.1210/clinem/dgaa071.
Texto completoLacey, Jean M., Carla Z. Minutti, Mark J. Magera, Angela L. Tauscher, Bruno Casetta, Mark McCann, James Lymp, Si Houn Hahn, Piero Rinaldo y Dietrich Matern. "Improved Specificity of Newborn Screening for Congenital Adrenal Hyperplasia by Second-Tier Steroid Profiling Using Tandem Mass Spectrometry". Clinical Chemistry 50, n.º 3 (1 de marzo de 2004): 621–25. http://dx.doi.org/10.1373/clinchem.2003.027193.
Texto completoKösel, Siegfried, Siegfried Burggraf, Ralph Fingerhut, Helmut G. Dörr, Adelbert A. Roscher y Bernhard Olgemöller. "Rapid Second-Tier Molecular Genetic Analysis for Congenital Adrenal Hyperplasia Attributable to Steroid 21-Hydroxylase Deficiency". Clinical Chemistry 51, n.º 2 (1 de febrero de 2005): 298–304. http://dx.doi.org/10.1373/clinchem.2004.042416.
Texto completoWong, T., C. H. Shackleton, T. R. Covey y G. Ellis. "Identification of the Steroids in Neonatal Plasma that Interfere with 17 Alpha-Hydroxyprogesterone Radioimmunoassays". Clinical Chemistry 38, n.º 9 (1 de septiembre de 1992): 1830–37. http://dx.doi.org/10.1093/clinchem/38.9.1830.
Texto completoMaeda, M., H. Arakawa, A. Tsuji, Y. Yamagami, A. Isozaki, T. Takahashi y E. Haruki. "Enzyme-linked immunosorbent assay for 17 alpha-hydroxyprogesterone in dried blood spotted on filter paper." Clinical Chemistry 33, n.º 6 (1 de junio de 1987): 761–64. http://dx.doi.org/10.1093/clinchem/33.6.761.
Texto completoRobinson, Janet A., J. Dyas, I. A. Hughes y Diana Riad-Fahmy. "Radioimmunoassay of Blood-Spot 17α-Hydroxyprogesterone in the Management of Congenital Adrenal Hyperplasia". Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 24, n.º 1 (enero de 1987): 58–65. http://dx.doi.org/10.1177/000456328702400109.
Texto completoWong, Felix C. K., Angela Z. Chan, W. S. Wong, Angel H. W. Kwan, Tracy S. M. Law, Jacqueline P. W. Chung, Jeffrey S. S. Kwok y Angel O. K. Chan. "Hyperandrogenism, Elevated 17-Hydroxyprogesterone and Its Urinary Metabolites in a Young Woman with Ovarian Steroid Cell Tumor, Not Otherwise Specified: Case Report and Review of the Literature". Case Reports in Endocrinology 2019 (27 de octubre de 2019): 1–8. http://dx.doi.org/10.1155/2019/9237459.
Texto completoKeevil, Brian, Kyriakie Sarafoglou, David Moriarty, Michael Huang, Chris Barnes y Wiebke Arlt. "Assessment of Steroid Hormones in Both Saliva and Blood During a Phase 2 Clinical Trial for the Use of Tildacerfont in Adults With Classic Congenital Adrenal Hyperplasia". Journal of the Endocrine Society 5, Supplement_1 (1 de mayo de 2021): A1012. http://dx.doi.org/10.1210/jendso/bvab048.2070.
Texto completoMcCartney, Christopher R., Amy B. Bellows, Melissa B. Gingrich, Yun Hu, William S. Evans, John C. Marshall y Johannes D. Veldhuis. "Exaggerated 17-hydroxyprogesterone response to intravenous infusions of recombinant human LH in women with polycystic ovary syndrome". American Journal of Physiology-Endocrinology and Metabolism 286, n.º 6 (junio de 2004): E902—E908. http://dx.doi.org/10.1152/ajpendo.00415.2003.
Texto completoSoardi, Fernanda Caroline, Sofia Helena V. Lemos-Marini, Fernanda Borchers Coeli, Víctor Gonçalves Maturana, Márcia Duarte Barbosa da Silva, Renan Darin Bernardi, Giselle Zenker Justo y Maricilda Palandi de-Mello. "Heterozygosis for CYP21A2 mutation considered as 21-hydroxylase deficiency in neonatal screening". Arquivos Brasileiros de Endocrinologia & Metabologia 52, n.º 8 (noviembre de 2008): 1388–92. http://dx.doi.org/10.1590/s0004-27302008000800030.
Texto completoEl-Maouche, Diala, Deborah P. Merke, Maria G. Vogiatzi, Alice Y. Chang, Adina F. Turcu, Elizabeth G. Joyal, Vivian H. Lin et al. "A Phase 2, Multicenter Study of Nevanimibe for the Treatment of Congenital Adrenal Hyperplasia". Journal of Clinical Endocrinology & Metabolism 105, n.º 8 (26 de junio de 2020): 2771–78. http://dx.doi.org/10.1210/clinem/dgaa381.
Texto completoGhizzoni, Lucia, Marco Cappa, Alessandra Vottero, Graziamaria Ubertini, Daniela Carta, Natascia Di Iorgi, Valentina Gasco et al. "Relationship of CYP21A2 genotype and serum 17-hydroxyprogesterone and cortisol levels in a large cohort of Italian children with premature pubarche". European Journal of Endocrinology 165, n.º 2 (agosto de 2011): 307–14. http://dx.doi.org/10.1530/eje-11-0119.
Texto completoLiu, Jian, Xuemei Qiu, Daoming Wang, Yantao Li, Yang Zong, Yichen Liu, Yue Zhang et al. "Quantification of 10 steroid hormones in human saliva from Chinese adult volunteers". Journal of International Medical Research 46, n.º 4 (22 de febrero de 2018): 1414–27. http://dx.doi.org/10.1177/0300060517752733.
Texto completoJiang, Xiang, Fang Tang, Yi Feng, Bei Li, Xuefang Jia, Chengfang Tang, Sichi Liu y Yonglan Huang. "The adjustment of 17-hydroxyprogesterone cut-off values for congenital adrenal hyperplasia neonatal screening by GSP according to gestational age and age at sampling". Journal of Pediatric Endocrinology and Metabolism 32, n.º 11 (26 de noviembre de 2019): 1253–58. http://dx.doi.org/10.1515/jpem-2019-0140.
Texto completoXu, Y. Y., K. Pettersson, K. Blomberg, I. Hemmilä, H. Mikola y T. Lövgren. "Simultaneous Quadruple-Label Fluorometric Immunoassay of Thyroid-Stimulating Hormone, 17 α-Hydroxyprogesterone, Immunoreactive Trypsin, and Creatine Kinase MM Isoenzyme in Dried Blood Spots". Clinical Chemistry 38, n.º 10 (1 de octubre de 1992): 2038–43. http://dx.doi.org/10.1093/clinchem/38.10.2038.
Texto completoCan, Esra y Oluş Api. "Evaluation of fetal stress in preeclamptic patients". Perinatal Journal 28, n.º 1 (1 de abril de 2020): 7–10. http://dx.doi.org/10.2399/prn.20.0281002.
Texto completoCastro, Patrícia S., Tatiana O. Rassi, Raquel F. Araujo, Isabela L. Pezzuti, Andresa S. Rodrigues, Tania A. S. S. Bachega y Ivani N. Silva. "High frequency of non-classical congenital adrenal hyperplasia form among children with persistently elevated levels of 17-hydroxyprogesterone after newborn screening". Journal of Pediatric Endocrinology and Metabolism 32, n.º 5 (27 de mayo de 2019): 499–504. http://dx.doi.org/10.1515/jpem-2018-0398.
Texto completoReinehr, Thomas, Juliane Rothermel, Andreas Wegener-Panzer, Michaela F. Hartmann, Stefan A. Wudy y Paul-Martin Holterhus. "Vanishing 17-Hydroxyprogesterone Concentrations in 21-Hydroxylase Deficiency". Hormone Research in Paediatrics 90, n.º 2 (2018): 138–44. http://dx.doi.org/10.1159/000487927.
Texto completoCrain, Courtney, Kathryn Stambough, Lefkothea Karaviti y Oluyemisi Adeyemi-Fowode. "28. Elevated 17-Hydroxyprogesterone (17-OHP) in Ovarian Sertoli-Leydig Cell Tumor". Journal of Pediatric and Adolescent Gynecology 34, n.º 2 (abril de 2021): 250. http://dx.doi.org/10.1016/j.jpag.2021.02.032.
Texto completoIbáñez, Lourdes, Neus Potau, Maria Victoria Marcos y Francis de Zegher. "Corticotropin-Releasing Hormone: A Potent Androgen Secretagogue in Girls with Hyperandrogenism after Precocious Pubarche1". Journal of Clinical Endocrinology & Metabolism 84, n.º 12 (1 de diciembre de 1999): 4602–6. http://dx.doi.org/10.1210/jcem.84.12.6239.
Texto completoHatun, Sükrü, Nurşen Yordam y Ali Süha Çalikoǧlu. "Serum 3α-androstanediol glucuronide measurements in children with congenital adrenal hyperplasia". European Journal of Endocrinology 131, n.º 5 (noviembre de 1994): 504–8. http://dx.doi.org/10.1530/eje.0.1310504.
Texto completoClausen, Caroline S., Marie L. Ljubicic, Katharina M. Main, Anna-Maria Andersson, Jørgen H. Petersen, Hanne Frederiksen, Morten Duno, Trine H. Johannsen y Anders Juul. "Congenital Adrenal Hyperplasia in Children: A Pilot Study of Steroid Hormones Expressed as Sex- and Age-Related Standard Deviation Scores". Hormone Research in Paediatrics 93, n.º 4 (2020): 226–38. http://dx.doi.org/10.1159/000509079.
Texto completoHeather, Natasha L. y Anna Nordenstrom. "Newborn Screening for CAH—Challenges and Opportunities". International Journal of Neonatal Screening 7, n.º 1 (13 de febrero de 2021): 11. http://dx.doi.org/10.3390/ijns7010011.
Texto completoSaito, M., T. Yoshino, Y. Kawamoto, H. Bando, Y. Arimura, N. Fuse, M. Tahara, T. Doi y A. Ohtsu. "Association of hypersensitivity reactions to oxaliplatin with cumulative dose of oxaliplatin." Journal of Clinical Oncology 29, n.º 4_suppl (1 de febrero de 2011): 584. http://dx.doi.org/10.1200/jco.2011.29.4_suppl.584.
Texto completoThao Hoang, Phuong, Tsay Eric, John Mace y Eba Hathout. "Congenital Adrenocortical Tumor in an Asymptomatic Neonate with Positive Newborn Screen for Congenital Adrenal Hyperplasia: A Case Report". International Journal of Integrative Pediatrics and Environmental Medicine 3 (14 de febrero de 2017): 1–4. http://dx.doi.org/10.36013/ijipem.v3i0.30.
Texto completoJanzen, N., M. Peter, S. Sander, U. Steuerwald, M. Terhardt, U. Holtkamp y J. Sander. "Newborn Screening for Congenital Adrenal Hyperplasia: Additional Steroid Profile using Liquid Chromatography-Tandem Mass Spectrometry". Journal of Clinical Endocrinology & Metabolism 92, n.º 7 (1 de julio de 2007): 2581–89. http://dx.doi.org/10.1210/jc.2006-2890.
Texto completoMakela, S. K. y G. Ellis. "Nonspecificity of a direct 17 alpha-hydroxyprogesterone radioimmunoassay kit when used with samples from neonates." Clinical Chemistry 34, n.º 10 (1 de octubre de 1988): 2070–75. http://dx.doi.org/10.1093/clinchem/34.10.2070.
Texto completoRamos, Clarissa Cerchi A., Lucas Ricci Bento, Ezequiel Moreira Gonçalves, Maricilda Palandi de Mello, Maria Tereza M. Baptista, Sofia Helena V. de Lemos-Marini y Gil Guerra-Júnior. "Avaliação do crescimento, do controle laboratorial e da corticoterapia em um grupo de pacientes com a forma clássica da deficiência da 21-hidroxilase". Revista Paulista de Pediatria 25, n.º 4 (diciembre de 2007): 317–23. http://dx.doi.org/10.1590/s0103-05822007000400004.
Texto completoWallace, A. M., G. H. Beastall, B. Cook, A. J. Currie, A. M. Ross, R. Kennedy y R. W. A. Girdwood. "Neonatal screening for congenital adrenal hyperplasia: a programme based on a novel direct radioimmunoassay for 17-hydroxyprogesterone in blood spots". Journal of Endocrinology 108, n.º 2 (febrero de 1986): 299–308. http://dx.doi.org/10.1677/joe.0.1080299.
Texto completoYusuf, Zenab I., Deepa Dongarwar, Rafeek A. Yusuf y Hamisu M. Salihu. "Oral Health Problems among Children with Neurodevelopmental Disorders in the United States". International Journal of Maternal and Child Health and AIDS (IJMA) 9, n.º 1 (10 de febrero de 2020): 157–60. http://dx.doi.org/10.21106/ijma.342.
Texto completoEkbom, K. "Pain and Stress Response during Intravenous Access in Children with Congenital Adrenal Hyperplasia: Effects of EMLA and Nitrous Oxide Treatment". Pain Research and Treatment 2017 (31 de diciembre de 2017): 1–7. http://dx.doi.org/10.1155/2017/1793241.
Texto completoPott, Janne, Katrin Horn, Robert Zeidler, Holger Kirsten, Peter Ahnert, Jürgen Kratzsch, Markus Loeffler, Berend Isermann, Uta Ceglarek y Markus Scholz. "Sex-Specific Causal Relations between Steroid Hormones and Obesity—A Mendelian Randomization Study". Metabolites 11, n.º 11 (28 de octubre de 2021): 738. http://dx.doi.org/10.3390/metabo11110738.
Texto completoKresch, Eliyahu, Daniel Gonzalez, Jesse Ory, Sirpi Nackeeran, Ruben Blachman-Braun, Manuel Molina y Ranjith Ramasamy. "Impact of Short-Acting vs Long-Acting Testosterone Therapy on Intratesticular Testosterone Using Data From Two Open-Label Randomized Clinical Trials of Testosterone Pellets, Injections, and Intranasal Gel in Hypogonadal Men". Journal of the Endocrine Society 5, Supplement_1 (1 de mayo de 2021): A758—A759. http://dx.doi.org/10.1210/jendso/bvab048.1543.
Texto completoSherman, M., S. Younger y J. Sherman. "1309 Elevated 17-Hydroxyprogesterone [17-Ohp] Levels: A Fetoplacental Mechanism to Prevent Preterm Birth?" Archives of Disease in Childhood 97, Suppl 2 (1 de octubre de 2012): A373. http://dx.doi.org/10.1136/archdischild-2012-302724.1309.
Texto completoSoliman, A. T. "Congenital Adrenal Hyperplasia: Family Screening Using 17-hydroxyprogesterone (17-OHP) Response to Adrenocorticotopin (ACTH)". Journal of Tropical Pediatrics 52, n.º 2 (16 de noviembre de 2005): 147–48. http://dx.doi.org/10.1093/tropej/fmi089.
Texto completoVotava, Felix, Dóra Török, József Kovács, Dorothea Möslinger, Sabina M. Baumgartner-Parzer, János Sólyom, Zuzana Pribilincová et al. "Estimation of the false-negative rate in newborn screening for congenital adrenal hyperplasia". European Journal of Endocrinology 152, n.º 6 (junio de 2005): 869–74. http://dx.doi.org/10.1530/eje.1.01929.
Texto completoDiramerian, Linda Garabet, Bianca Russell y Harvey Chiu. "ODP375 Absence of Virilization With Completely Normal Phenotype in a Newborn Female With Salt-Wasting Classical CAH". Journal of the Endocrine Society 6, Supplement_1 (1 de noviembre de 2022): A598—A599. http://dx.doi.org/10.1210/jendso/bvac150.1240.
Texto completoSouto, Selma B., Pedro V. Baptista, Filomena Barreto, Pedro F. Sousa, Daniel C. Braga y Davide Carvalho. "Ovarian intratumoral 21-hydroxylase deficiency in a postmenopausal hirsute woman". Arquivos Brasileiros de Endocrinologia & Metabologia 56, n.º 9 (diciembre de 2012): 672–76. http://dx.doi.org/10.1590/s0004-27302012000900012.
Texto completoKnochenhauer, E. S., C. Cortet-Rudelli, R. D. Cunnigham, B. A. Conway-Myers, D. Dewailly y R. Azziz. "Carriers of 21-Hydroxylase Deficiency Are Not at Increased Risk for Hyperandrogenism*". Journal of Clinical Endocrinology & Metabolism 82, n.º 2 (1 de febrero de 1997): 479–85. http://dx.doi.org/10.1210/jcem.82.2.3759.
Texto completo